| Literature DB >> 24039168 |
Gianni Colotti1, Andrea Ilari, Annarita Fiorillo, Paola Baiocco, Maria Agostina Cinellu, Laura Maiore, Federica Scaletti, Chiara Gabbiani, Luigi Messori.
Abstract
Picking a fight with parasites! Trypanothione reductase (TR) is a validated drug target for the development of antileishmanial agents. A group of structurally diverse gold-containing compounds was evaluated in vitro for TR inhibition. A number of compounds exhibited potent activity and deserve further pharmacological evaluation.Entities:
Keywords: Leishmania; antiprotozoal agents; gold; inhibitors; trypanothione reductase
Mesh:
Substances:
Year: 2013 PMID: 24039168 DOI: 10.1002/cmdc.201300276
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466